Medical

James Holly, M.D.

Sept. 23, 2017, I wrote CVS CEO Larry Merlo, expressing my concerns about CVS’ use of its Pharmacy Management Benefits (PBM) program to further intrude into healthcare. The letter also summarized SETMA’s extensive clinical tools for supporting the appropriate and safe prescribing of opioid medications including the electronic prescribing of controlled substances.

Sept. 28, 2017, I received a response from CVS Health’s Executive Vice President and Chief Medical Officer. Here is that response and my observations.

shadow